Identifying biomarkers of treatment efficacy in an efficient and accurate way is the key to a successful clinical trial. From biomarker discovery to the development of companion diagnostics, Todsys Health is helping pharmaceutical companies shortening the distance between early target discovery and commercial launch.
We provide comprehensive cancer TodsysHealth profiling to facilitate biomarker discovery. Customized assay is available.
From next generation sequencing, IHC and PCR assay, we utilize various platforms to screen patients prospectively.
Our team of industry veterans and in-house clinical database offer insights to ensure a smooth clinical trial operations.
We offer companion diagnostic development on NGS-based or CHIP-based multiplex qPCR platforms.
© 2019 Todsyshealth. All rights reserved.